Certara

Poster

First-in-human dosing model for MDX2004, a novel trispecific CD3xCD28/4-1BB antibody-fusion protein for advanced malignancies

Learn how QSP modeling enabled safe, data-driven FIH dose prediction for the trispecific T-cell activator…

CertaraDecember 16, 2025

Webinar

From Unstructured Data to Dose Insights: Applying Modern AI to Exposure Bracketing

CertaraDecember 16, 2025

Announcement

Certara Announces New Release of Integral® Software

Latest version enhances efficiency, compliance, and user experience for PK scientists Radnor, PA. — December…

Danielle PillsburyDecember 16, 2025

Case Study

Accelerated ADC Approval Through Expert Modeling and Data Rescue

See how Certara rescued complex ADC PK datasets, delivered PopPK, exposure-response modeling, and enabled rapid…

CertaraDecember 15, 2025

Case Study

Merck Advances Pediatric Oncology with Innovative ADC Modeling

Merck leveraged ADC modeling and pediatric ADC dose optimization to enable FDA acceptance and advance…

CertaraDecember 12, 2025

Blog

How to build standardized eCRFs across multiple EDC systems

Discover how to build standardized eCRFs across multiple EDC systems to improve data quality, accelerate…

CertaraDecember 12, 2025

Conference

ICoP 2026 India

Danielle PillsburyDecember 11, 2025

Press Release

Certara Appoints Jon Resnick as Chief Executive Officer

Resnick brings decades of leadership experience in health sciences, business operations, strategy, innovation and commercial…

CertaraDecember 11, 2025

Podcast Press Coverage

New Approach Methodologies: Redefining Animal Testing Alternatives

Explore how New Approach Methodologies (NAMs) and advanced in silico and in vitro tools are…

CertaraDecember 10, 2025